Published in Saudi J Biol Sci on February 20, 2010
The micronucleus test. Mutat Res (1975) 3.53
Food-derived bioactive peptides--opportunities for designing future foods. Curr Pharm Des (2003) 1.57
In vitro and in vivo evidence suggesting a role for iron in cisplatin-induced nephrotoxicity. Kidney Int (1998) 1.45
Sustained levels of ascorbic acid are toxic and immunosuppressive for human T cells. P R Health Sci J (1996) 1.42
Determination of tea components with antioxidant activity. J Agric Food Chem (2003) 1.30
Milk protein-derived peptide inhibitors of angiotensin-I-converting enzyme. Br J Nutr (2000) 1.22
Cisplatin generates superoxide anion by interaction with DNA in a cell-free system. Biochem Biophys Res Commun (1994) 1.16
Antimutagenic and some other effects of conjugated linoleic acid. Br J Nutr (2000) 1.03
Genotoxicity of bleomycin. Mutat Res (1991) 1.01
Antioxidant activity and radioprotective effects against chromosomal damage induced in vivo by X-rays of flavan-3-ols (Procyanidins) from grape seeds (Vitis vinifera): comparative study versus other phenolic and organic compounds. J Agric Food Chem (2000) 0.98
Multiple circus movement tachycardias with multiple accessory pathways. J Am Coll Cardiol (1984) 0.95
Modifying effect of vitamins C, E and beta-carotene against gamma-ray-induced DNA damage in mouse cells. Mutat Res (1998) 0.94
Chemical mutagen testing on in vivo somatic mammalian cells. Agents Actions (1973) 0.92
Protection of conjugated linoleic acids against 2-amino-3- methylimidazo[4,5-f]quinoline-induced colon carcinogenesis in the F344 rat: a study of inhibitory mechanisms. Carcinogenesis (1995) 0.92
Proceedings: Biosynthesis and composition of milk. J Invest Dermatol (1974) 0.92
Effect of diet and vitamin C on DNA strand breakage in freshly-isolated human white blood cells. Mutat Res (1994) 0.86
Role of ascorbic acid on mercuric chloride-induced genotoxicity in human blood cultures. Toxicol In Vitro (2001) 0.85
Kinetics of micronucleus formation in relation to chromosomal aberrations in mouse bone marrow. Mutat Res (1984) 0.85
In vivo anticlastogenic effects of L-ascorbic acid in mice. Mutat Res (1999) 0.84
Camels' milk: for drinking only? Comp Biochem Physiol A Comp Physiol (1984) 0.84
Inhibition of cyclophosphamide and mitomycin C-induced sister chromatid exchanges in mice by vitamin C. Cancer Res (1986) 0.82
Chemotherapy-induced chromosomal damage in peripheral blood lymphocytes of cancer patients supplemented with antioxidants or placebo. Mutat Res (2001) 0.81
Vitamin content of camel milk. Int J Vitam Nutr Res (1992) 0.81
The effect of antioxidants on bleomycin treatment in in vitro and in vivo genotoxicity assays. Mutat Res (1995) 0.81
The influence of "selenium organicum" upon the hepatic function of carbon tetrachloride poisoned rats. Rom J Intern Med (1996) 0.81
Modulation of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-induced mutation in the cecum and colon of big blue rats by conjugated linoleic acid and 1,2-dithiole-3-thione. Nutr Cancer (2001) 0.81
Trace elements and their distribution in protein fractions of camel milk in comparison to other commonly consumed milks. J Dairy Res (2001) 0.81
Vitamin C mediated protection on cisplatin induced mutagenicity in mice. Mutat Res (1998) 0.81
Protection and induction of chromosomal damage by vitamin C in human lymphocyte cultures. Teratog Carcinog Mutagen (1999) 0.81
Effect of vitamins C and E on toxicity and mutagenicity of hexavalent chromium in rat and guinea pig. Mutat Res (1991) 0.80
Antimutagenic effects of casein and its digestion products. Food Chem Toxicol (1993) 0.80
Inhibition of adriamycin-induced micronuclei by desferrioxamine in Swiss albino mice. Mutat Res (1993) 0.79
In vivo antimutagenic effect of vitamins C and E against rifampicin-induced chromosome aberrations in mouse bone-marrow cells. Mutat Res (2002) 0.79
Micronucleus test in bone marrow of mice treated with 1-nitropropane, 2-nitropropane and cisplatin. Mutat Res (1987) 0.79
Differential effects of milk proteins, BSA and soy protein on 4NQO- or MNNG-induced SCEs in V79 cells. Food Chem Toxicol (1994) 0.79
Cisplatin-induced genotoxic effects and endogenous glutathione levels in mice bearing ascites Dalton's lymphoma. Mutat Res (2003) 0.79
Antimutagenic effects of garlic extract on chromosomal aberrations. Cancer Lett (2002) 0.78
Increased frequency of chromosomal damage in peripheral blood lymphocytes up to nine years following curative chemotherapy of patients with testicular carcinoma. Environ Mol Mutagen (1991) 0.78
Vitamin C-mediated minimisation of Rogor-induced genotoxicity. Mutat Res (1993) 0.78
Fatty acids and lipids of camel milk and colostrum. Int J Food Sci Nutr (2001) 0.78
Milk and milk products in human nutrition. FAO Nutr Stud (1972) 0.78
Vitamin E protection from/potentiation of the cytogenetic toxicity of cisplatin in Swiss mice. J Chemother (2002) 0.78
Natural and man-made mutagens and carcinogens in the human diet. Mutat Res (1999) 0.77
Effect of selenium on cadmium genotoxicity investigated by micronucleus assay. Vet Med (Praha) (1997) 0.76
Direct effect of inorganic mercury on citrate uptake by isolated rat renal brush border membrane vesicles. Ind Health (1997) 0.76
Supplementation with vitamins C and E suppresses leukocyte oxygen free radical production in patients with myocardial infarction. Eur Heart J (1995) 0.76
Clastogenic effects of cis-diamminedichloroplatinum. I. Induction of chromosomal aberrations in somatic and germinal cells of mice. Mutat Res (1989) 0.76
Clastogenic effect of cisplatin on Wistar rat bone marrow cells. Braz J Med Biol Res (1995) 0.76
Concentration-dependent antioxidant activities of conjugated linoleic acid and α-tocopherol in corn oil. J Sci Food Agric (2007) 0.76
Induction of micronuclei and granular chromatin condensation in human skin fibroblasts influenced by cisplatin (cis-DDP) in vitro. Mutat Res (1994) 0.76
Protective effect of zinc on cadmium-induced micronuclei in V79 cells. J Trace Elem Med Biol (2000) 0.76
Cytogenetic toxicity of cisplatin in bone marrow cells of Swiss mice. J Chemother (2000) 0.76
Cisplatin induced cell killing and chromosomal aberrations in CHO cells: treated during G1 or S phase. Mutat Res (1993) 0.76